Showing results (2211-2220 of 8,157) with videos related to
Sort By:
Pageof 816
Haematologica|January 12, 2005
Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarinMark A Crowther, Walter Ageno, Terri Schnurr, et al.Haematologica|February 3, 2004
Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromesFrancesca Guidetti, Sandra Grazioli, Francesca Capelli, et al.Haematologica|February 3, 2004
P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groupsOllivier Legrand, Simona Zompi, Jean-Yves Perrot, et al.Haematologica|February 3, 2004
Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapyThoralf Lange, Thomas Bumm, Sandra Otto, et al.Haematologica|February 3, 2004
Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignanciesClara Bueno, Julia Almeida, Paulo Lucio, et al.Haematologica|June 15, 2004
Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemiaRosana Marta, Nora Goette, Paola Lev, et al.Haematologica|June 15, 2004
Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?Muriel Giansily-Blaizot, Régis Verdier, Christine Biron-Adréani, et al.Haematologica|June 15, 2004
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO)Giovanni Barosi, Mario Boccadoro, Michele Cavo, et al.Haematologica|June 15, 2004
Instability of PRV-1 mRNA: a factor to be considered in PRV-1 quantification for the diagnosis of polycythemia veraJaroslav Jelinek, Katerina Jedlickova, Yongli Guan, et al.Haematologica|June 15, 2004
Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphomaStefan Hohaus, Annalaura Di Febo, Sergio Storti, et al.Pageof 816